Tue, 20 Oct 2026
03:29:59 pm
Rudransh Sangwan
Published at: October 16, 2026, 5:47 AM
Synopsis
HDB Financial Services shares fall 3.06% to ₹522.55. Read the latest share price, Q2 profit growth, ₹2 dividend, analyst ratings and stock returns.

HDB Financial Services shares fell 3.06% to ₹522.55 on the NSE on October 16, 2026, according to price data updated at 11:07 AM IST. The stock declined ₹16.56 during the session after opening at ₹539.10 and touching an intraday high of ₹540.95.
The share price was trading near its 52 week low of ₹519.50. The decline came amid weak recent performance, with the stock down 22.84% over one month and 29.05% over one year.
| Metric | Details |
|---|---|
| Share price | ₹522.55 |
| Daily price change | -3.06% |
| Previous close | ₹539.11 |
| Opening price | ₹539.10 |
| Intraday high | ₹540.95 |
| Intraday low | ₹519.50 |
| Trading volume | 13.06 lakh shares |
| Market capitalisation | ₹43,379.93 crore |
| P/E ratio | 14.66 |
| EPS, trailing 12 months | ₹35.63 |
| Price to book ratio | 2.17 |
| 52 week high | ₹796.70 |
| 52 week low | ₹519.50 |
The stock has recorded negative returns across the one week, one month, three month and one year periods listed in the supplied data.
| Period | Share price return |
|---|---|
| 1 day | -2.96% |
| 1 week | -11.13% |
| 1 month | -22.84% |
| 3 months | -30.46% |
| 1 year | -29.05% |
The supplied return data shows a 30.46% decline over three months. The latest intraday price of ₹522.55 was also close to the reported 52 week low, reflecting continued weakness in the stock price.
A report dated October 14, 2026, said HDB Financial Services' second quarter profit increased 34% year on year, while its net interest margin (NIM) improved year on year. The report also highlighted the company's focus on stronger disbursements in the second half of the financial year.
Profit growth and improving NIM are relevant indicators for a lender, but investors would need to assess the full results, including asset quality, credit costs, loan growth and funding expenses, to understand the broader financial performance.
HDB Financial Services announced a dividend of ₹2 per share on October 14, 2026, with October 23, 2026, set as the record date, according to the supplied stock information.
Eligible shareholders should check the company's official announcement for the applicable eligibility and payment details.
The supplied data shows a Buy consensus among 16 analysts. The breakdown includes four Strong Buy, four Buy, six Hold and two Sell recommendations, with no Strong Sell ratings.
The mixed recommendations indicate differing analyst views. Ratings and target prices are estimates, not guarantees of future performance.
Investors tracking HDB Financial Services can monitor loan disbursements, net interest margins, asset quality, credit costs and future earnings. The upcoming dividend record date is another company development to note.
Although the reported quarterly profit growth offers a positive financial indicator, the stock's recent returns remain negative. The available data does not establish a specific reason for the share price decline on October 16. This article is for information only and is not investment advice.

Financial journalist specializing in market analysis, stock research, and investment trends. Dedicated to providing accurate, timely insights for informed decision-making.
Credentials: Experienced financial journalist with expertise in equity markets and economic analysis
The information provided in this article is for educational and informational purposes only and should not be construed as financial, investment, or legal advice. welomoney does not provide personalized investment recommendations.
For detailed terms and conditions, please read our Disclaimer and Terms of Service.

L&T has begun preliminary work on the New Tashkent International Airport project after receiving a limited notice to proceed.

DLF share price has 41% upside, according to HSBC’s target. Compare Jefferies, CLSA and other broker views on sales, cash flow and valuations.

Divi's Laboratories shares rose 1.01% to Rs 9,242.50 after a positive EU opinion on Eli Lilly's weight loss drug Foundayo. See the growth outlook.

Awfis revenue target exceeds Rs 1,800 crore for FY27, with flexible workspace demand supporting growth. Expansion and execution remain key to watch.

L&T has won a contract worth over Rs 15,000 crore. The client, project scope and execution timeline remain undisclosed, leaving its revenue impact...